Drugmakers request changes to FDA’s mass balance studies guidance

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsComplianceNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy